2006, Blood Pressure and DEA - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2006

Blood Pressure

DEA

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

SEPTEMBER 23, 2019

33 Adults and adolescents may experience increased blood pressure and respiratory rates, red eyes, dry mouth, increased appetite, and slurred speech. 5 In 1970, the DEA classified marijuana as a Schedule I drug, which is defined as a drug with no current acceptable medical use and a high potential for abuse.

Cannabinoids

Cannabinoids Marijuana Research and Development Access

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

28) Side effects noted included strangely enough, vomiting and abdominal pain, psychiatric side effects including depression and paranoia, and low blood pressure. Cell Calcium 39 (2006) 155–162. 32: United States DEA. 27) A 1998 study found a low potential for abuse and no indication of patients chasing the drug. (28)

Extraction

Extraction Pharmaceutical CBD Epilepsy

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Stay Connected